Thermodilution has less bias and reduced heteroscedasticity than indirect Fick cardiac output in #VAD patients compared to gold standard direct Fick. @Brian_Houston12
🔗:https://t.co/cW1L2fsSf6
#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease.
#ESCCongress
Read our News and Views by @RyanTedfordMD and colleagues @MUSChealth for an insightful discussion into SGLT-2 inhibitors for treatment of #heartfailure with preserved ejection fraction.
https://t.co/1dlqGHragp
Proud to announce the publication of CAPITAL DOREMI in @NEJM - a comparison of milrinone and dobutamine in cardiogenic shock. Contrary to the hypothesis milrinone was not superior to dobutamine in this randomized double blind comparison. https://t.co/XUz7fCR2GG